Brigham and Women's Hospital is the second largest teaching hospital of Harvard Medical School and the largest hospital in the Longwood Medical Area in Boston, Massachusetts.

There are 793 beds in Brigham and Women's Hospital/Harvard Medical School.

During the past decade, Brigham and Women's Hospital/Harvard Medical School conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Brigham and Women's Hospital/Harvard Medical School" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials sponsored, "AlloVir" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "AnGes USA, Inc." with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brigham and Women's Hospital/Harvard Medical School" #1 collaborator was "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Autoimmunity Centers of Excellence" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Critical Path Institute - Predictive Safety Testing Consortium" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Brigham and Women's Hospital/Harvard Medical School" are "COVID-19" (2 trials), "Multiple Sclerosis" (2 trials), "Autoimmune Diseases" (1 trials), "BK Virus Infection" (1 trials) and "BK Virus Nephropathy" (1 trials). Many other conditions were trialed in "Brigham and Women's Hospital/Harvard Medical School" in a lesser frequency.

Most popular intervention types in "Brigham and Women's Hospital/Harvard Medical School" are "Drug" (11 trials), "Biological" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Remdesivir" (2 trials), "Standard of Care" (2 trials), "AMG0001" (1 trials) and "Albuterol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brigham and Women's Hospital/Harvard Medical School" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Brigham and Women's Hospital/Harvard Medical School". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Brigham and Women's Hospital/Harvard Medical School, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Brigham and Women's Hospital/Harvard Medical School, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".